Wall Street Analysts Are Neutral on Top Healthcare Picks

Wall Street analysts have issued neutral ratings for Vertex Pharmaceuticals (VRTX) and Travere Therapeutics (TVTX), indicating that experts are neither bullish nor bearish on these healthcare stocks. Stifel Nicolaus analysts maintained Hold ratings for both companies, with specific price targets set. Despite these neutral stances, the consensus among analysts for both VRTX and TVTX is a Strong Buy, with significant upside potential from current levels.